Development of predictive assay for progression of slow-onset type 1 diabetes and its application to disease prevention
慢发 1 型糖尿病进展预测测定的开发及其在疾病预防中的应用
基本信息
- 批准号:18590994
- 负责人:
- 金额:$ 2.53万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Japanese type 1 diabetes (T1D) is a heterogeneous disease characterized by the different clinical features in terms of its mode of onset or age at disease onset. It is estimated that the prevalence of adult-onset T1D is similar to that of childhood-onset T1D, and that around two-thirds of adult-onset T1D are categorized in "slow-onset T1D". Although anti-glutamic acid decarboxylase 65 (GAD65) antibodies are good predictive marker for future insulin deficiency in slow-onset T1D, positive predictive value at 5 years is about 65% and one-thirds of GAD65 antibody-positive patients do not need insulin therapy for long period. Therefore, in order to develop the highly predictive marker for future insulin deficiency in slow-onset T1D we performed a fine epitope mapping of anti-AD65 antibodies using random phage display technology.1. Preparation of human islet GAD random phage display libraryIn the first year we prepared a human islet GAD random phage display library, and screened this library with pooled sera from patients with slow-onset T1D and healthy control subjects. After amplifying the individual clone that reacted with sera from patients or controls, the PCR-direct sequence analysis was performed to determine the specific DNA sequence for GAD65 molecule.2. Development of anti-GAD epitope-specific antibody measurementWith the results obtained in the first year, we tried to identify the specific epitopes associated with the progression to insulin deficiency in slow-onset T1D patients by sandwich ELISA method. There were many difficulties to identify the diabetes-specific epitopes for GAD antibodies using random phage display library system with ELISA because of the high Noise/Signal ratio.We are trying to do the fine epitope mapping using other detection systems.
日本1型糖尿病(T1D)是一种异质性疾病,其特征在于在发病模式或发病年龄方面具有不同的临床特征。据估计,成人发作T1D的患病率与儿童期发作T1D的患病率相似,约三分之二的成人发作T1D被归类为“缓慢发作T1D”。尽管抗谷氨酸脱羧酶65(GAD 65)抗体是慢发型T1D患者未来胰岛素缺乏的良好预测标志物,但5年时的阳性预测值约为65%,三分之一的GAD 65抗体阳性患者不需要长期胰岛素治疗。因此,为了开发未来胰岛素缺乏症的高度预测标记物,我们使用随机噬菌体展示技术进行了抗AD65抗体的精细表位作图。人胰岛GAD噬菌体随机展示文库的制备第一年,我们制备了人胰岛GAD噬菌体随机展示文库,并用来自慢发型T1D患者和健康对照者的混合血清筛选该文库。扩增与患者或对照血清反应的单个克隆后,进行PCR直接测序分析,以确定GAD65分子的特异性DNA序列.抗GAD表位特异性抗体测量的开发利用第一年获得的结果,我们试图通过夹心ELISA方法鉴定与慢发型T1 D患者胰岛素缺乏进展相关的特异性表位。由于随机噬菌体抗体库系统结合ELISA法检测GAD抗体的信噪比较高,难以准确定位GAD抗体的表位,本研究尝试利用其他检测系统进行精细的表位定位。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Etiology of type 1 diabetes-immunological mechanism
1型糖尿病病因-免疫机制
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:E.;Kawasaki
- 通讯作者:Kawasaki
Diagnosis of acute-onset type 1 diabetes in Japan From the view point of humoral autoimmunity
从体液自身免疫的角度诊断日本急性发作的1型糖尿病
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:E.;Kawasaki
- 通讯作者:Kawasaki
Current aspects on the clinical immunology and genetics of autoimmune diabetes in Japan
日本自身免疫性糖尿病的临床免疫学和遗传学现状
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:E. Kawasaki
- 通讯作者:E. Kawasaki
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KAWASAKI Eiji其他文献
KAWASAKI Eiji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KAWASAKI Eiji', 18)}}的其他基金
Clarification of pathogenetic mechanisms of type 1 diabetes and its adaptation to prediction and prevention
阐明1型糖尿病的发病机制及其对预测和预防的适应
- 批准号:
23591310 - 财政年份:2011
- 资助金额:
$ 2.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of predictive marker for the progression of type 1 diabetes using a newly discovered autoantigen
使用新发现的自身抗原开发 1 型糖尿病进展的预测标记
- 批准号:
20591064 - 财政年份:2008
- 资助金额:
$ 2.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of predictive marker for type 1 diabetes development using GAD antibody epitope analysis and its application to disease prevention
利用GAD抗体表位分析鉴定1型糖尿病发展的预测标记及其在疾病预防中的应用
- 批准号:
15590947 - 财政年份:2003
- 资助金额:
$ 2.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Understanding the impact of type 1 diabetes and statin use on vascular cells
了解 1 型糖尿病和他汀类药物的使用对血管细胞的影响
- 批准号:
MR/Y001028/1 - 财政年份:2024
- 资助金额:
$ 2.53万 - 项目类别:
Research Grant
Maternal extracellular vesicles as key mediators of fetal growth and offspring cardiometabolic health in pregnancies complicated by type-1 diabetes.
母体细胞外囊泡是妊娠并发 1 型糖尿病时胎儿生长和后代心脏代谢健康的关键介质。
- 批准号:
MR/Y003659/1 - 财政年份:2024
- 资助金额:
$ 2.53万 - 项目类别:
Research Grant
Enabling precision medicine in type 1 diabetes (T1D): leveraging integrative multiomics to understand T1D endotypes for therapy
实现 1 型糖尿病 (T1D) 的精准医疗:利用综合多组学了解 T1D 内型以进行治疗
- 批准号:
491380 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
Fellowship Programs
Engineered TCR-Treg Cell Therapies Targeting Type 1 Diabetes Autoantigens
针对 1 型糖尿病自身抗原的工程化 TCR-Treg 细胞疗法
- 批准号:
10764143 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes
原位胰岛新抗原在人类 1 型糖尿病中的发现及其作用
- 批准号:
10589578 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
Mechanisms by which PIM kinase modulates the effector function of autoreactive CD8 T cells in type 1 diabetes
PIM 激酶调节 1 型糖尿病自身反应性 CD8 T 细胞效应功能的机制
- 批准号:
10605431 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
School-Partnered Collaborative Care (SPACE) for Pediatric Type 1 Diabetes
针对儿童 1 型糖尿病的学校合作协作护理 (SPACE)
- 批准号:
10640614 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
Tolerance-Inducing mRNA Nanoparticles to Treat Type 1 Diabetes
诱导耐受的 mRNA 纳米颗粒治疗 1 型糖尿病
- 批准号:
10835326 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
Analysis of Type 1 Diabetes Polygenic Scores in Atypical Forms of Diabetes
非典型糖尿病 1 型糖尿病多基因评分分析
- 批准号:
10750644 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别: